How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper



Neumann, Eva, Schreeck, Filippa, Herberg, Jethro, Aigrain, Evelyne Jacqz, Maitland-van der Zee, Anke H, Perez-Martinez, Antonio, Hawcutt, Daniel B ORCID: 0000-0002-8120-6507, Schaeffeler, Elke, Rane, Anders, de Wildt, Saskia N
et al (show 1 more authors) (2022) How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY.

[img] Text
Neuman et al. BrJClinPharmacol revised version BJCP-RT-00487-21.docx - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (327kB)
Item Type: Article
Uncontrolled Keywords: clinical trials, epigenomics, OMICS technology, paediatrics, pharmacogenomics
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 25 Mar 2022 08:26
Last Modified: 09 Sep 2022 04:10
DOI: 10.1111/bcp.15216
Open Access URL: https://bpspubs.onlinelibrary.wiley.com/doi/10.111...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3151418